welcome
Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Business

Business & Economics

Stifel Affirms Buy Rating on Illumina (ILMN) Stock

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
Summary
Nutrition label

82% Informative

Analysts at Stifel are bullish about Illumina , Inc.’s (NASDAQ:ILMN) prospects despite the stock capitulating 36% year to date .

Illumina is a life science company that develops and manufactures tools and systems for genomics research.

It offers a range of products and services, including sequencing platforms and microarrays.

VR Score

85

Informative language

88

Neutral language

18

Article tone

formal

Language

English

Language complexity

59

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links